Home » RXi Pharmaceuticals Gets FDA Clearance to Start Clinical Trial for a Drug Candidate Designed to Reduce Scarring
RXi Pharmaceuticals Gets FDA Clearance to Start Clinical Trial for a Drug Candidate Designed to Reduce Scarring
RXi Pharmaceuticals said that it has received clearance for its investigational new drug application from the FDA.
The Boston Globe
The Boston Globe
Upcoming Events
-
07May
-
14May
-
30May